94 related articles for article (PubMed ID: 10608783)
1. Amantadine and rimantadine have no direct inhibitory effects against hepatitis C viral protease, helicase, ATPase, polymerase, and internal ribosomal entry site-mediated translation.
Jubin R; Murray MG; Howe AY; Butkiewicz N; Hong Z; Lau JY
J Infect Dis; 2000 Jan; 181(1):331-4. PubMed ID: 10608783
[TBL] [Abstract][Full Text] [Related]
2. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.
Kanda T; Yokosuka O; Imazeki F; Fujiwara K; Nagao K; Saisho H
Biochem Biophys Res Commun; 2005 Jun; 331(2):621-9. PubMed ID: 15850805
[TBL] [Abstract][Full Text] [Related]
3. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.
Krüger M; Beger C; Welch PJ; Barber JR; Manns MP; Wong-Staal F
Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272
[TBL] [Abstract][Full Text] [Related]
4. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis C virus IRES-mediated translation by oligonucleotides.
Li X; Mueller S; Wimmer E
Virus Res; 2009 Dec; 146(1-2):29-35. PubMed ID: 19720092
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein.
Shimazaki T; Honda M; Kaneko S; Kobayashi K
Hepatology; 2002 Jan; 35(1):199-208. PubMed ID: 11786977
[TBL] [Abstract][Full Text] [Related]
7. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
[TBL] [Abstract][Full Text] [Related]
8. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
Pudi R; Ramamurthy SS; Das S
J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
[TBL] [Abstract][Full Text] [Related]
9. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3.
Yasmeen A; Hamid S; Granath FN; Lindström H; Elliott RM; Siddiqui AA; Persson MA
J Viral Hepat; 2006 Feb; 13(2):87-95. PubMed ID: 16436126
[TBL] [Abstract][Full Text] [Related]
10. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
[TBL] [Abstract][Full Text] [Related]
11. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
Jarczak D; Korf M; Beger C; Manns MP; Krüger M
FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
[TBL] [Abstract][Full Text] [Related]
12. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
[TBL] [Abstract][Full Text] [Related]
13. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein.
Shimoike T; Koyama C; Murakami K; Suzuki R; Matsuura Y; Miyamura T; Suzuki T
Virology; 2006 Feb; 345(2):434-45. PubMed ID: 16297950
[TBL] [Abstract][Full Text] [Related]
15. Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses.
Dasgupta A; Das S; Izumi R; Venkatesan A; Barat B
FEMS Microbiol Lett; 2004 May; 234(2):189-99. PubMed ID: 15135522
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the interferon alpha response against hepatitis C virus replicons.
Guo JT; Sohn JA; Zhu Q; Seeger C
Virology; 2004 Jul; 325(1):71-81. PubMed ID: 15231387
[TBL] [Abstract][Full Text] [Related]
17. A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice.
McCaffrey AP; Meuse L; Karimi M; Contag CH; Kay MA
Hepatology; 2003 Aug; 38(2):503-8. PubMed ID: 12883495
[TBL] [Abstract][Full Text] [Related]
18. hnRNP L is required for the translation mediated by HCV IRES.
Hwang B; Lim JH; Hahm B; Jang SK; Lee SW
Biochem Biophys Res Commun; 2009 Jan; 378(3):584-8. PubMed ID: 19061868
[TBL] [Abstract][Full Text] [Related]
19. Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein.
Li D; Lott WB; Martyn J; Haqshenas G; Gowans EJ
J Virol; 2004 Nov; 78(21):12075-81. PubMed ID: 15479850
[TBL] [Abstract][Full Text] [Related]
20. Autogenous translational inhibition of core protein: implication for switch from translation to RNA replication in hepatitis C virus.
Zhang J; Yamada O; Yoshida H; Iwai T; Araki H
Virology; 2002 Feb; 293(1):141-50. PubMed ID: 11853407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]